Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
Summary generated by The Flow from the publisher's feed. The full article lives at DeepMind Blog.
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.
arXiv:2606. 07562v1 Announce Type: cross Abstract: RNA design consists of discovering a nucleotide sequence that optimizes predefined criteria, such as secondary structure.
Explore how AlphaFold has accelerated science and fueled a global wave of biological discovery.
arXiv:2605. 14066v2 Announce Type: replace-cross Abstract: Early-stage Parkinson's disease (EarlyPD) detection from speech is clinically meaningful yet underexplored, and published results are hard to compare because studies differ in datasets, languages, tasks, evaluation protocols, and EarlyPD definitions.
arXiv:2606. 14788v1 Announce Type: cross Abstract: Voice-based screening offers a scalable and non-invasive way to assess neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), but their staging remains challenging due to the difficulty of integrating heterogeneous data.
